RxDoctor Payments Data

Crystal Mick

Psychiatric/Mental Health · Shenandoah, IANPI 1801566054

Payments from drug & device makers

$700in general payments, 2019–2025

Across 42 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$233
  • AbbVie$113
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$106
  • Teva Pharmaceuticals USA, Inc.$52
  • Takeda Pharmaceuticals U.S.A., Inc.$24
  • Lundbeck LLC$24
  • plus $148 from 8 others

What the payments were for

  • Food & beverage$700100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$700 in reported general payments places this provider in the 45th percentile of 443 psychiatric/mental health providers in Iowa.

See all psychiatric/mental health providers in Iowa

Medicare billing

Part B allowed, 2024
$6,429
Medicare patients
14
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine11$118,870
VraylarCariprazine Hcl21$29,607
BelsomraSuvorexant21$10,872
Lurasidone Hcl17$5,244
Aripiprazole26$1,514
Paliperidone ErPaliperidone12$1,012
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine31$739
Hydroxyzine Hcl34$457
Buspirone Hcl41$414
Vilazodone Hcl11$358
Prazosin Hcl19$358
Desvenlafaxine Succinate ErDesvenlafaxine Succinate23$314
Venlafaxine Hcl ErVenlafaxine Hcl51$268
Mirtazapine17$143
Gabapentin11$109

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$52$118,87011 claims
AbbVieVraylar$113$29,60721 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 443 psychiatric/mental health providers in Iowa.

Other psychiatric/mental health in Shenandoah

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →